A5016934429- Antibiotic Resistance in Bacteria
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- Antibiotics Pharmacokinetics and Efficacy
- Bacterial Identification and Susceptibility Testing
- COVID-19 diagnosis using AI
- Bacterial biofilms and quorum sensing
- Respiratory viral infections research
- Diphtheria, Corynebacterium, and Tetanus
- Mycobacterium research and diagnosis
- Streptococcal Infections and Treatments
- COVID-19 Clinical Research Studies
- Bacteriophages and microbial interactions
- Antibiotic Use and Resistance
Instituto de investigación sanitaria y biomédica de Alicante
2022-2024
Hospital General Universitario de Alicante Doctor Balmis
2022-2024
Organización Nacional de Trasplantes
2023
TIE Kinetix (Germany)
2023
Hospital Universitario 12 De Octubre
2023
The presence of neutralizing antibodies (NAbs) against SARS-CoV-2 represent a surrogate marker immunologic protection in populations at high risk infection such as healthcare workers caring for hospitalized patients with COVID-19. As recommended by CDC and the European CDC, use rapid diagnostic tests during population-based evaluations offers an opportunity to identify individuals serologic evidence natural or who have undergone vaccination. We carried out cross-sectional study assess among...
The “One Health” approach provides a comprehensive framework for understanding antimicrobial resistance. This perspective is of particular importance in the study Pseudomonas aeruginosa, as it not only pathogen that affects humans but also persists environmental reservoirs. To assess evolutionary selection niche-specific traits, genomic comparison 749 P. aeruginosa strains from three environments (clinical, aquatic, and soil) was performed. results showed environment does indeed exert...
Carbapenem-resistant Pseudomonas aeruginosa infections represent a critical public health concern, highlighting the need for development of effective antibiotics. Cefiderocol demonstrated potent in vitro activity against aeruginosa, particularly strains that are resistant to other drugs. However, concerns regarding emergence drug-resistant persist. This study, conducted with 109 carbapenem-resistant from Spanish Hospital (Dr. Balmis, Alicante). The study evaluated susceptibility cefiderocol...
ABSTRACT Rapid microbiological diagnosis of the antibiotic susceptibility Gram-negative bacilli is a priority in clinical microbiology, especially cases bacteremia. The rapid advancement antimicrobial resistance proposes challenge for empirical therapy and shows need fast diagnostics to guide treatments. QuickMIC System (Gradientech AB, Uppsala, Sweden) recently developed diagnostic tool testing. Our study evaluates phenotypic system (QuickMIC) that provides information on 12 antibiotics...
Pseudomonas aeruginosa shows resistance to several antibiotics and often develops such during patient treatment.Develop an in vitro model, using clinical isolates of P. aeruginosa, compare the ability imipenem imipenem/relebactam generate resistant mutants other antibiotics. Perform a genotypic analysis detect how selective pressure changes their genomes.The was studied by microdilution assays e-test, study performed NGS.The acquired average 6 days, 12 days (p value = 0.004). After 30...